J. Goldman & Co »

Axsome Therapeutics shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 28k 79.59
2023-09-30 $3.8M 54k 69.89
2023-06-30 $1.1M 16k 71.86
2023-03-31 $3.8M 62k 61.68
2022-12-31 $208k 2.7k 77.13
2019-12-31 $3.5M 34k 103.38
2019-09-30 $1.4M 71k 20.22
2019-06-30 $1.9M 75k 25.73
2019-03-31 $2.5M 177k 14.22